$AMGN Company News NYSE to expand number of companies

New Post Public Reply Private Reply Replies (0) Message Board

Oct 17, 2014 at 11:07 AM

$AMGN Company News

NYSE to expand number of companies on biotech index 5:52 p.m. Oct. 14, 2014 - Wallace Witkowski
Charting a Fed-induced market whipsaw 11:20 a.m. Oct. 9, 2014 - Michael Ashbaugh
Dow industrials venture to uncharted territory 9:53 a.m. Sept. 17, 2014 - Michael Ashbaugh
Nasdaq breaks out, reaches less-charted territory 12:05 p.m. Aug. 19, 2014 - Michael Ashbaugh
Nasdaq breaks out, reaches less-charted territory 11:56 a.m. Aug. 19, 2014 - Michael Ashbaugh
Nasdaq breaks out, reaches less-charted territory 11:44 a.m. Aug. 19, 2014 - Michael Ashbaugh
Berkshire Hathaway tops $200,000; Cisco drops on results 12:19 p.m. Aug. 14, 2014 - Angela Johnson
Cisco volatile after hours in wake of earnings 5:03 p.m. Aug. 13, 2014 - Sue Chang
Amgen recalls syringes of anemia drug Aranesp 4:55 p.m. Aug. 13, 2014 - Russ Britt
CORRECT: Amgen shares fall after-hours on disappointing trial data 4:34 p.m. Aug. 13, 2014 - Tomi Kilgore
U.S. stocks rally; Dow snaps 4-session losing streak 4:14 p.m. Aug. 4, 2014 - Barbara Kollmeyer
Mobileye rises for second day; Michael Kors falls 1:23 p.m. Aug. 4, 2014 - Angela Johnson
Amgen shares rally 2.7% to top S&P 500 9:30 a.m. Aug. 4, 2014 - Sue Chang
Amgen reports successful late-stage trial of cancer treatment 8:34 a.m. Aug. 4, 2014 - Joshua Jamerson
Amgen reports positive trial of multiple myeloma treatment 7:49 a.m. Aug. 4, 2014 - Ciara Linnane
Tesla Shares Weaken in After Hours 8:13 p.m. July 31, 2014 - MarketWatch
Small health companies see large gains on a big earnings day 5:34 p.m. July 30, 2014 - blogs.marketwatch.com
Twitter, U.S. Steel soar; Buffalo Wild Wings are burned 4:26 p.m. July 30, 2014 - MarketWatch
Edwards, Hospira rise as health-care companies see strong earnings 1:08 p.m. July 30, 2014 - blogs.marketwatch.com
Amgen shares hit record on cost-cutting plans 10:50 a.m. July 30, 2014 - blogs.marketwatch.com

Amgen Files Patent Infringement Suit 9:43 a.m. Today - The Wall Street Journal Interactive Edition
Amgen sues Sanofi and Regeneron 9:30 a.m. Today - Seeking Alpha
Amgen Files Lawsuit Against Sanofi And Regeneron For Patent Infringement 8:01 a.m. Today - benzinga.com
New Positive Clinical Data Supports Quest Towards Orphan Designations 6:45 a.m. Today - Seeking Alpha
3 Stocks Dragging In The Drugs Industry 1:22 p.m. Oct. 16, 2014 - TheStreet.com
Ad Comm meeting approaches for Novartis' psoriasis therapy candidate 11:46 a.m. Oct. 16, 2014 - Seeking Alpha
Biotech Stock Roundup: Gilead Nabs FDA Nod for Combo HCV Drug, Auxilium Accepts Endo Offer - Analyst Blog 1:59 p.m. Oct. 15, 2014 - Zacks.com
'Fast Money' Recap: Now May Be the Time to Buy Energy Stocks 5:00 a.m. Oct. 15, 2014 - TheStreet.com
6 Useful Categories of Stocks 12:02 p.m. Oct. 14, 2014 - GuruFocus.com
Novartis Releases Data on Secukinumab for Plaque Psoriasis - Analyst Blog 5:57 p.m. Oct. 13, 2014 - Zacks.com
Amgen's Blinatumomab Gets Priority Review in the U.S. - Analyst Blog 5:55 p.m. Oct. 13, 2014 - Zacks.com
UBS Very Positive on Top Biotech Stocks Ahead of Earnings 7:58 a.m. Oct. 13, 2014 - 247WallSt.com
Most Top Industry Groups Fall Harder Than Market 5:35 p.m. Oct. 10, 2014 - Investors Business Daily
Today's Stocks Driving Success For The Drugs Industry 1:03 p.m. Oct. 10, 2014 - TheStreet.com
Amgen spin-out on deck for IPO 11:29 a.m. Oct. 10, 2014 - Seeking Alpha
Short Interest in Biotech Becomes Company Specific 9:24 a.m. Oct. 10, 2014 - 247WallSt.com
Put Amgen Back on Your Buy List 8:52 p.m. Oct. 9, 2014 - InvestorPlace.com
Amgen Up on Positive Phase III Data on Psoriasis Biosimilar - Analyst Blog 3:54 p.m. Oct. 9, 2014 - Zacks.com
UPDATE: Amgen's BiTE Received FDA Priority Review Designation 3:06 p.m. Oct. 9, 2014 - benzinga.com
Portfolio Changes For The Third Quarter 2014 9:14 a.m. Oct. 9, 2014 - Seeking Alpha

Amgen Files Lawsuit Against Sanofi And Regeneron For Patent Infringement 9:00 a.m. Today - PR Newswire - PRF
Alirocumab (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 6:40 p.m. Oct. 14, 2014 - PR Newswire - PRF
Welfare Initiatives, Clinical Data Presentation, Financing Plan, Regulatory Disclosure, and Positive Drug Trials - Research Reports on Johnson & Johnson, Merck, Medtronic, Covidien and Amgen 8:35 a.m. Oct. 13, 2014 - PR Newswire - PRF
Amgen's BiTE® Immunotherapy Blinatumomab Receives FDA Priority Review Designation In Acute Lymphoblastic Leukemia 4:05 p.m. Oct. 9, 2014 - PR Newswire - PRF
Amgen Announces Positive Top-Line Results From Phase 3 Study Evaluating The Efficacy And Safety Of Biosimilar Candidate ABP 501 Compared With Adalimumab In Patients With Moderate-To-Severe Plaque Psoriasis 9:15 a.m. Oct. 8, 2014 - PR Newswire - PRF
Global Biosimilar Market Outlook 2018 8:09 p.m. Oct. 1, 2014 - PR Newswire - PRF
The Lancet Publishes Two Phase 3 Studies Showing Cholesterol-Lowering Medication Evolocumab Significantly Reduced LDL Cholesterol In Patients With Serious Genetic Disorders That Cause High Cholesterol 7:01 p.m. Oct. 1, 2014 - PR Newswire - PRF
Earnings Release Schedules, Data Presentation, Regulatory Approvals, and Strategic Collaboration - Research Reports on Covidien, Biogen, Amgen, Agios and Baxter 8:55 a.m. Oct. 1, 2014 - PR Newswire - PRF
Bococizumab (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 3:55 p.m. Sept. 29, 2014 - PR Newswire - PRF
Amgen to Host Summary Webcast of Kyprolis® (carfilzomib) for Injection Data Presented at The European Society for Medical Oncology (ESMO) 2014 Congress 5:02 p.m. Sept. 24, 2014 - PR Newswire - PRF
Q Therapeutics Expands Board of Directors With Appointment of Dr. Hunter Jackson as Independent Member 4:22 p.m. Sept. 23, 2014 - Marketwire
Regulatory Approval, Presentation of Data, Appointment, Clinical Study Results, and Increase in Quarterly Dividend - Research Reports on Johnson & Johnson, Merck, Medtronic, Amgen and Covidien 9:05 a.m. Sept. 23, 2014 - PR Newswire - PRF
Amgen Submits Biologics License Application for Investigational BiTE® Immunotherapy Blinatumomab 9:00 a.m. Sept. 22, 2014 - PR Newswire - PRF
New Analyses Of Phase 2 Study Presented At ASBMR Show Romosozumab Treatment Resulted In Continued Increases In Bone Mineral Density 4:00 p.m. Sept. 15, 2014 - PR Newswire - PRF
Event Schedules, Survey Findings, Regulatory Filings, and Market Activity - Research Reports on Amgen, Biogen Idec, Salix, Covidien and Shire 8:50 a.m. Sept. 15, 2014 - PR Newswire - PRF
Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 9:00 p.m. Sept. 14, 2014 - PR Newswire - PRF
Reporting Bias in Clinical Trials: What's the current status? 10:30 a.m. Sept. 10, 2014 - PR Newswire - PRF
Amgen Announces 23 Abstracts To Be Presented At The American Society for Bone and Mineral Research 2014 Annual Meeting 9:15 a.m. Sept. 10, 2014 - PR Newswire - PRF
Critical Alerts For Alcoa, Twitter, General Mills, SunEdison and Amgen Released By InvestorsObserver 9:31 a.m. Sept. 9, 2014 - PR Newswire - PRF
Zenith Epigenetics Strengthens its Management Team with Key Appointments 5:34 p.m. Sept. 8, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Revolutionizing Textiles: Touchscreen Garments Emerge

Picture a world where your shirt does more than just cover your back. Bingo, folks—smart textiles have taken center stage with groundbreaking technology that melds touchscreens with fabric, and the brains behind it hail from the National University of Singapore (NUS). It's not just about slapping a few LEDs onto a vest. We're talking about clothing that can display...

OTconnect on Apple Watch: A New Fitness Era Dawns

What’s Orangetheory Up To Now? Ah, fitness gadgets, where everyone’s seemingly got a scheme brewing. This time it's Orangetheory (OTF), turning your Apple Watch into your new best gym buddy. October 22, 2026, marks the launch of OTconnect for Apple Watch, offering a slick way for enthusiasts to tune into their own sweat metrics. If you’re already an Apple Watch...

LEDC and Crosson Lead the Charge in Community Finance

Recognizing Game-Changers in Community Development Finance In the financial landscape, it's not always about the big tickers and glitzy IPOs. Sometimes, it's the intrepid ground-level players who make the real difference. That's exactly what happened when the Opportunity Finance Network (OFN) held its 42nd annual conference in New Orleans, honoring standouts in the realm...

Unicycive's Stock Plunge: Fraud Suit and FDA Hurdles

Unicycive's Tumultuous Journey Lately, it's been a rocky road for Unicycive Therapeutics, Inc., with their stock free-falling 39.1% in the span of a heartbeat on June 30, 2026. What sparked this nosedive? The FDA kicked back their revised New Drug Application for a kidney disease treatment yet again, spotlighting old manufacturing issues never nipped in the bud. Talk...

Navigating Car Accidents in Connecticut: Essential Steps

Understanding the Immediate Chaos Post-Accident Alright, picture this: you've just been in a car accident in Connecticut. Your heart's pounding, and the scene's full of chaos. But here's the kicker - the actions you take now are crucial. It's easy to focus on the crumpled metal of your vehicle, but there's more at stake here. The decisions you make in these moments can...

Texas A&M-San Antonio Opens $55M Health Hub

Building Blocks for Future Health Experts They say money talks, and down in San Antonio, it just shouted loud and clear. Texas A&M University-San Antonio sliced the ribbon on a $55 million Public Health and Education building, a step that isn’t just about bricks and mortar, but life-saving insights and hands-on training that'll ripple across South Texas. This isn’t...

California Waste Solutions: Investing in Vietnam's Future

Some folks see trash. David Duong sees hope—and dollar signs. This man ain't just talking trash collection; he's flipping waste into opportunity and, more importantly, into core community building in Vietnam. Over at Vietnam Waste Solutions, a subsidiary of California Waste Solutions, they're blending environmental breakthroughs with good old-fashioned community values....

Oakworth Capital's Strategic Gains: A Deep Dive

Oakworth Capital's Big Moves This Quarter Diving right into the Alabama-based Oakworth Capital's latest numbers, they did not pull any punches with a hefty 19% bump in net income. Now, in a world where banking can sometimes feel like riding a porcupine, Oakworth's ability to rise above speaks volumes. They clocked in at $17.2 million net income for the year-to-date period...

Xona's $250M Raise: GPS Transformation Sparks Debate

The Satellite Race Heats Up: Xona's Ambitious Leap Hold onto your hats, folks, because Xona's making headlines with a $250 million infusion. This ain't just pocket change—it's part of a rocket-fueled mission to upend the GPS landscape. Imagine a world where GPS is 100 times stronger. That's the pitch, and folks, it's got the market buzzing. Valuation Rocketing: Investor...

Low GWP Refrigerants: Potential $13B Market by 2031

Refrigerants: They're Hot in More Ways Than One Who would've thought refrigerants could be such a big deal? But here we are. The low global warming potential (GWP) refrigerants market is heating up, projected to jump from $8.17 billion in 2026 to a whopping $13.06 billion by 2031. That's a solid 9.8% CAGR if you're keeping score. The drivers? Well, we’ve got...